Showing results (1-10 of 348) with videos related to

Sort By:
Pageof 35
Cancer Discovery|December 15, 2015
Targeting CDK4 and CDK6: From Discovery to TherapyCharles J Sherr, David Beach, Geoffrey I Shapiro
Cancer Cell|December 13, 2017
Genomic Biomarkers Predicting Response to Selective CDK4/6 Inhibition: Progress in an Elusive SearchGeoffrey I Shapiro
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridolGeoffrey I Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2006
Cyclin-dependent kinase pathways as targets for cancer treatmentGeoffrey I Shapiro
Cell|January 28, 2004
Principles of tumor suppressionCharles J Sherr
Molecular Cell|May 23, 2006
Autophagy by ARF: a short storyCharles J Sherr
Cell Cycle (Georgetown, Tex.)|January 17, 2004
An Arf(GFP/GFP) reporter mouse reveals that the Arf tumor suppressor monitors latent oncogenic signals in vivoCharles J Sherr
Nature Reviews. Cancer|August 18, 2006
Divorcing ARF and p53: an unsettled caseCharles J Sherr
Wiley Interdisciplinary Reviews. Developmental Biology|September 11, 2012
Ink4-Arf locus in cancer and agingCharles J Sherr
Expert Opinion on Therapeutic Targets|October 12, 2010
Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumorsNeil Johnson, Geoffrey I Shapiro
Pageof 35